Study of the inhibitory effects on malignant progression and anticancer drug sensitivity of human squamous cell carcinoma by intensifying cell to cell communication
通过加强细胞间通讯抑制人鳞状细胞癌恶性进展和抗癌药物敏感性的研究
基本信息
- 批准号:17592100
- 负责人:
- 金额:$ 1.66万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2005
- 资助国家:日本
- 起止时间:2005 至 2006
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Malatolate (Diisoprppyl, 1, 3-dithio1-2-ylidenemalonate, MT) is clinically used as a hepatoprotective agent. Because we noticed that MT induced the differetiation of cultured vascular endothelial cell, we examined the inhibitory effects of MT on invasion of oral squamous cell carcinoma cell (SCC) lines (SAS, Ca9-22, HSC-2,-3,-4) and analyzed its mechanisms of intensifying endothelial and tumor cell to cell adhesion. Five SCC cell lines and rat lung endothelial (RLE) cells were grown in a mixed medium of DMEM and D/F-12 supplemented 10% fetal bovine serum. The invasion capacity of the SCC cells was measured by counting the number of colonies /cm2 formed under the RLE monolayer using a phase contrast microscope. Intercellular junctional communication was examined by the scrape-loading assay. The percentage of cells coupled with the scrape edge was determined by the number of dye-transferred cells. Morphological changes in RLE monolayer observed with electron microscope. Connexin43 expres … More sion of RLE treated with MT was analyzed by western blotting. In an in vitro invasion assay using a RLE monolayer, invasion of tumor cells which had been treated with MT (10ng/ml, 24h) was not affected; however, when had been treated with MT, invasion was significantly inhibited in three cell lines (p<0. 01). Electron-microscopical examination of the RLE monolayer treated with MT showed the development of gap junction like structure. The cell to cell communication increased in RLE monolayers treated with MT(82. 5%), compared to non-treated with MT(32. 5%). A junction associated protein, cnnexin43 was also elevated at RLE and SAS treated with MT. In vivo growth of SAS tumor, primary tumor size was reduced in MT+CDDP treated nude mice compared with CDDP treated nude mice. Conclusion: These findings suggests that MT suppressed tumor cell invasion by intensifying the cell-cell adhesion of vascular endothelium and that enhanced anticancer drug sensitivity by modifying tumor cell communication. Less
恶性甲酸(Diisoppyl,1,3-Dithio1-2-甲状腺素,MT)在临床上用作肝保护剂。因为我们注意到MT诱导了培养的血管内皮细胞的差异,所以我们检查了MT对侵袭口服鳞状细胞癌细胞(SCC)细胞(SAS,CA9-22,HSC-2,-3,-4)的抑制作用,并分析了其强度内皮细胞和Tumor细胞的机制。在DMEM的混合培养基和D/F-12补充10%胎牛血清的混合培养基中生长了五个SCC细胞系和大鼠内皮细胞(RLE)细胞。通过计算使用相对比显微镜在RLE单层下形成的菌落 /CM2的数量来测量SCC细胞的侵袭能力。通过刮擦加载测定法检查了细胞间连通通信。结合刮擦边缘的细胞百分比由染料转让细胞的数量确定。用电子显微镜观察到的RLE单层的形态变化。 connexin43表达…通过蛋白质印迹分析了更多用MT处理的RLE。在使用RLE单层的体外侵袭测定中,未影响用MT(10ng/ml,24H)处理的肿瘤细胞的侵袭。但是,当用MT处理MT时,在三个细胞系中浸润显着抑制(p <0。01)。用MT处理的RLE单层的电子显微镜检查表明,间隙连接如结构的发展。与未经MT治疗的MT(32.5%)相比,用MT处理的RLE单层中的细胞通信增加(82.5%)。连接相关的蛋白质,CNNexin43在RLE和用MT处理的SAS上也升高。与CDDP处理过的裸鼠相比,在MT+CDDP处理的裸鼠中,MT+CDDP治疗的MT+CDDP治疗的裸小鼠的原发性肿瘤大小降低。结论:这些发现表明,MT通过增强血管内皮细胞 - 细胞粘合剂来抑制肿瘤细胞的侵袭,并通过修饰肿瘤细胞通信来增强抗癌药物敏感性。较少的
项目成果
期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Management of Oral Psychosomatic Disorders in Oral Medicine Consultatin Clinics in Cooperation with Psychosomatic Medicine and Medical Psychology Clinics
与心身医学和医学心理学诊所合作的口腔医学咨询诊所的口腔心身疾病管理
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:M.Saitoh;Y.Abiko;T.Kawakami;Y.Ikeda;H.Nagayasu;et al.
- 通讯作者:et al.
「口腔内科相談外来」と「診療内科・医療心理室」との連携による口腔心身症患者へのアプローチ
“口腔咨询门诊”与“内科/医学心理室”合作,针对口腔心身疾病患者开展治疗
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:齋藤正人;安彦善裕;川上智史;池田和博;永易裕樹;木下憲治;宮崎友香;志賀満江;佐々木直;坂野雄二
- 通讯作者:坂野雄二
Inhibitory effects of fermented brown rice and rice bran on the development of acute hepatitis in Long-evans Cinamon rats
发酵糙米和米糠对 Long-evans Cinamon 大鼠急性肝炎发展的抑制作用
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:T.Shibata;H.Nagayasu;H;Kitajyo;M;Arisue;T Yamashita;D.Hatakeyama;T.Iwasaki;H.Kbayashi
- 通讯作者:H.Kbayashi
「口腔内科相談外来」と「心療内科・医療心理室」との連携による口腔心身症患者へのアプローチ
通过“口腔咨询门诊”与“心身内科/医学心理学室”合作,针对口腔心身疾病患者开展治疗
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:齋藤正人;安彦善裕;川上智史;池田和博;永易裕樹;木下憲治;宮崎友香;志賀満江;佐々木直;坂野雄二
- 通讯作者:坂野雄二
共 4 条
- 1
NAGAYASU Hiroki其他文献
Management of Oral Psychosomatic Disorders in Oral Medicine Consultation Clinic in Cooperation with Psychosomatic Medicine and Medical Psychology Clinics
心身医学、医学心理诊所合作口腔医学咨询诊所口腔心身疾病管理
- DOI:
- 发表时间:20062006
- 期刊:
- 影响因子:0
- 作者:SAITOH Masato;ABIKO Yoshihiro;KAWAKAMI Tomofumi;IKEDAYasuhiro;NAGAYASU Hiroki;KINOSHITA Kenji;MIYAZAKI Yuka;SHIGA Mitsue;SASAKI Tadashi;SAKANO YujiSAITOH Masato;ABIKO Yoshihiro;KAWAKAMI Tomofumi;IKEDAYasuhiro;NAGAYASU Hiroki;KINOSHITA Kenji;MIYAZAKI Yuka;SHIGA Mitsue;SASAKI Tadashi;SAKANO Yuji
- 通讯作者:SAKANO YujiSAKANO Yuji
共 1 条
- 1
NAGAYASU Hiroki的其他基金
Elucidation of the carcinogenic mechanism for the prevention of oral cancer caused by betel quid chewing
阐明咀嚼槟榔预防口腔癌的致癌机制
- 批准号:17K1191617K11916
- 财政年份:2017
- 资助金额:$ 1.66万$ 1.66万
- 项目类别:Grant-in-Aid for Scientific Research (C)Grant-in-Aid for Scientific Research (C)
Study of the effects of epidermal growth factor on genomic instability and malignant phenotype of oral squamous cell carcinoma cells
表皮生长因子对口腔鳞癌细胞基因组不稳定性及恶性表型影响的研究
- 批准号:1457190714571907
- 财政年份:2002
- 资助金额:$ 1.66万$ 1.66万
- 项目类别:Grant-in-Aid for Scientific Research (C)Grant-in-Aid for Scientific Research (C)
Study of the inhibitory effects on invasion and metastasis of human squamous cell carcinoma by intensifying endothelial cell to cell adhesion
增强内皮细胞与细胞粘附抑制人鳞状细胞癌侵袭和转移的研究
- 批准号:1267196012671960
- 财政年份:2001
- 资助金额:$ 1.66万$ 1.66万
- 项目类别:Grant-in-Aid for Scientific Research (C)Grant-in-Aid for Scientific Research (C)
相似国自然基金
自然选择在入侵海鞘转移阶段重塑种群遗传多样性的分子机制研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
自然选择在入侵海鞘转移阶段重塑种群遗传多样性的分子机制研究
- 批准号:42106098
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
幽门螺杆菌感染促进肿瘤相关成纤维细胞与胃癌细胞的互作及机制研究
- 批准号:31760328
- 批准年份:2017
- 资助金额:36.0 万元
- 项目类别:地区科学基金项目
LncRNA-GMAN调控胃癌细胞侵袭和转移的分子作用机制研究
- 批准号:31771540
- 批准年份:2017
- 资助金额:59.0 万元
- 项目类别:面上项目
互花米草入侵诱导土著昆虫素毒蛾宿主转移及种群扩增的成因
- 批准号:31670544
- 批准年份:2016
- 资助金额:62.0 万元
- 项目类别:面上项目
相似海外基金
Biomarker guided combinations for treating high-risk bladder cancer
生物标志物引导的组合治疗高危膀胱癌
- 批准号:1071887410718874
- 财政年份:2023
- 资助金额:$ 1.66万$ 1.66万
- 项目类别:
SBIR CONCEPT AWARD TO NOVOMEDIX- NOVEL SMALL MOLECULES FOR THE TREATMENT OF RHABDOMYOSARCOMA
NOVOMEDIX 荣获 SBIR 概念奖 - 用于治疗横纹肌肉瘤的新型小分子
- 批准号:1055929610559296
- 财政年份:2022
- 资助金额:$ 1.66万$ 1.66万
- 项目类别:
The Inhibition of HNSCC Growth and Metastasis by Targeting KDM4A
通过靶向 KDM4A 抑制 HNSCC 的生长和转移
- 批准号:1018062810180628
- 财政年份:2021
- 资助金额:$ 1.66万$ 1.66万
- 项目类别:
Tissue Damage-Driven Squamous Cell Carcinoma
组织损伤驱动的鳞状细胞癌
- 批准号:1054434310544343
- 财政年份:2021
- 资助金额:$ 1.66万$ 1.66万
- 项目类别:
Mechanisms of Epigenetic Plasticity in PDAC
PDAC表观遗传可塑性机制
- 批准号:1063449810634498
- 财政年份:2021
- 资助金额:$ 1.66万$ 1.66万
- 项目类别: